ERMA — Enorama Pharma AB Share News
0.000.00%
- SEK88.39m
- SEK86.29m
- SEK2.74m
Brief: Enorama Pharma Signs Agreement With MAE Holding
Brief: Enorama Pharma Jan-March Operating Loss Widens SEK 4.4 Mln
Brief: Enorama Pharma Q4 Operating Loss Widens To SEK 6.1 Million
Brief: Enorama Pharma Establishes Laboratory For Medical Cannabis
Brief: Enorama Pharma Signs Agreement With Mediigum LLC
Brief: Enorama Pharma Gets Questions From Swedish Medical Products Agency
Brief: Enorama Pharma AB Rights Issue Subscribed To 152 Percent
Brief: Enorama Pharma Jul-Sept Operating Loss Widens To SEK 3.3 Million
Brief: Enorama Pharma April-June Operating Loss Widens To SEK 3.1 Million
Brief: Enorama Pharma Q1 Operating Loss Widens To SEK 3.0 Million
Brief: Enorama Pharma AB To Loan Sek 3,5 Million From Swede Unipharma AB.
Brief: Enorama Pharma Shows Positive Results In Stability Study
Brief: Enorama Pharma AB Q4 Operating Loss Up At Sek 2.4 Million
Brief: Enorama Pharma Signs A Loan Agreement With Swede Unipharma
Brief: Enorama Pharma Bioequivalence Study Shows Positive Results
Brief: Enorama Pharma secures bridge financing of SEK 1.0 mln
Brief: Enorama Pharma Q3 operating loss widens to SEK 2.1 mln
Brief: Enorama Pharma starts cooperation with Dr. Reddy's Laboratories